Utility of urinary ctDNA to monitoring minimal residual disease in early breast cancer patients
{{output}}
Background: Cancer recurrence for patients with early breast cancer is significant. Patients will benefit from more non-invasive modes of monitoring and we aim to study the feasibility of urinary circulating tumor DNA (ctDNA) to ... ...
